Rosaria Arvia

Rosaria Arvia

Auto-generated profile, based on publicly available information

Rosaria Arvia

Department of Experimental and clinical Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
KZKrystyna Zakrzewska
Krystyna Zakrzewska
RARosaria Arvia
Rosaria Arvia
MTMaria Torcia
Maria Torcia
ACAnn Maria Clemente
Ann Maria Clemente
MTMichele Tanturli
Michele Tanturli
CFClodoveo Ferri
Clodoveo Ferri

18 June 2020 in Rheumatology
Verified
Journal Article
Open access
PDF file
RARosaria Arvia
Rosaria Arvia
Francesca MargheriFrancesca Margheri
Francesca Margheri
MSMaria Stincarelli
Maria Stincarelli
Anna LaurenzanaAnna Laurenzana
Anna Laurenzana
GFGabriella Fibbi
Gabriella Fibbi
KZKrystyna Zakrzewska
Krystyna Zakrzewska
Fibrosis is the most characteristic pathological hallmark of SSc, a connective tissue disease characterized by vascular and immunological abnormalities, inflammation and enhanced extracellular matrix production, leading to progressive fibrosis of skin and internal organs. We previously demonstrated that parvovirus B19 (B19V) can infect normal human dermal fibroblasts (NHDFs) and that B19V persists in SSc fibroblasts. In this study, we investigated whether parvovirus B19V is able to activate in vitro NHDFs and to induce in these cells some phenotypic features similar to that observed in the SSc fibroblasts. We preliminarily analysed the time course of B19V infection in cultured NHDFs, then we investigated the ability of B19V to induce cell migration, invasive phenotype and mRNA expression of some profibrotic and/or proinflammatory genes. We confirmed our previous findings that B19V infects NHDFs, but the infection is not productive. After incubation with B19V, NHDFs showed a significant increase of both migration and invasiveness, along with mRNA expression of different profibrotic genes (α-SMA, EDN-1, IL-6, TGF-β1 receptors 1 and 2, Col1α2), some genes associated with inflammasome platform (AIM2, IFI16, IL-1β, CASP-1) and genes for metalloprotease (MMP 2, 9 and 12). These data suggest that B19V can activate dermal fibroblasts and may have a role in the pathogenesis of fibrosis. B19V-induced fibroblast migration and invasiveness could be due to the B19V-associated MMP9 overexpression and activation. Moreover, the up-regulation of MMP12, typical of SSc, could link the B19V infection of fibroblasts to the anti-angiogenic process.

27 February 2023 in Aspects of Molecular Medicine
Verified
Journal Article
Open access
MSMaria Stincarelli
Maria Stincarelli
RARosaria Arvia
Rosaria Arvia
Simone GiannecchiniSimone Giannecchini
Simone Giannecchini